Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
HOOKIPA Pharma Inc. - Common Stock
(NQ:
HOOK
)
0.8403
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about HOOKIPA Pharma Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
HOOKIPA Pharma to Report Third Quarter 2022 Financial Results and Corporate Updates on November 14, 2022
November 07, 2022
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA to Participate in the Sidoti Micro-Cap Virtual Conference
November 02, 2022
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
10 Best Medical Stocks Under $5
↗
October 29, 2022
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...
Via
Talk Markets
Short Volatility Alert: HOOKIPA Pharma Inc.
↗
October 21, 2022
On Thursday, shares of HOOKIPA Pharma Inc. (NASDAQ: HOOK) experienced volatile short activity. After the activity, the stock price went up +4.96% to $1.27. The overall sentiment for HOOK has been...
Via
Benzinga
Recap: HOOKIPA Pharma Q2 Earnings
↗
August 11, 2022
HOOKIPA Pharma (NASDAQ:HOOK) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Recap: HOOKIPA Pharma Q1 Earnings
↗
May 16, 2022
HOOKIPA Pharma (NASDAQ:HOOK) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For May 16, 2022
↗
May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Via
Benzinga
HOOKIPA Pharma (NASDAQ: HOOK) Enters into Collaboration Deal with Roche to Develop HB-700 For KRAS-Mutated Cancers
October 20, 2022
HOOKIPA Pharma, Inc. (NASDAQ: HOOK) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development
Via
Spotlight Growth
Why Is Indonesia Energy (INDO) Stock Up Today?
↗
October 20, 2022
Indonesia Energy (INDO) stock is climbing higher on Thursday after the company announced the discovery of oil in one of its new wells.
Via
InvestorPlace
Why Is Hookipa (HOOK) Stock Up 26% Today?
↗
October 20, 2022
Hookipa (HOOK) stock is rocketing higher on Thursday after reaching a strategic collaboration and license agreement with Roche (RHHBF).
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 20, 2022
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million.
Via
Benzinga
HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers
October 20, 2022
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Hookipa Shares Jump On New Preclinical Data On Cancer Immunotherapies
↗
April 13, 2022
HOOKIPA Pharma Inc (NASDAQ: HOOK) has
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
August 29, 2022
Via
Benzinga
HOOKIPA Gets FDA Nod For Initial-Stage Prostate Cancer Study
↗
July 25, 2022
The U.S. Food and Drug Administration (FDA) has accepted HOOKIPA Pharma’s (NASDAQ: HOOK) Investigational New Drug (IND) application for HB-300, a novel arenaviral immunotherapy for the treatment of...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
June 22, 2022
Via
Benzinga
HOOKIPA Pharma's Return On Capital Employed Insights
↗
June 21, 2022
According to data from Benzinga Pro, during Q1, HOOKIPA Pharma's (NASDAQ:HOOK) reported sales totaled $1.45 million. Despite a 15.38% increase in earnings, the company posted a loss of $17.97 million.
Via
Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
↗
April 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
HOOKIPA Pharma: Q4 Earnings Insights
↗
March 24, 2022
HOOKIPA Pharma (NASDAQ:HOOK) reported its Q4 earnings results on Thursday, March 24, 2022 at 07:00 AM. Here's what investors need to know about the...
Via
Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
↗
April 10, 2022
Biotech stocks managed to carve out modest gains for the week ending April 8, defying the broader market weakness. The defensive nature of the stocks make them appealing in times of risk aversion.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 04, 2022
Gainers Cognition Therapeutics (NASDAQ:CGTX) shares increased by 26.2% to $3.28 during Monday's regular session. Trading volume for Cognition Therapeutics's stock...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
March 25, 2022
Via
Benzinga
HOOKIPA Pharma's Return On Capital Employed Overview
↗
March 25, 2022
Benzinga Pro data, HOOKIPA Pharma (NASDAQ:HOOK) reported Q4 sales of $3.90 million. Earnings fell to a loss of $21.23 million, resulting in a 5.96% decrease from last quarter....
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
March 24, 2022
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding...
Via
Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
↗
March 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
HOOKIPA Pharma Earnings Preview
↗
March 23, 2022
HOOKIPA Pharma (NASDAQ:HOOK) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Earnings Scheduled For March 24, 2022
↗
March 24, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to...
Via
Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
↗
March 20, 2022
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...
Via
Benzinga
How To Attend HOOKIPA Pharma Q4 2021 Earnings Conference Call
↗
March 18, 2022
HOOKIPA Pharma (NASDAQ:HOOK) will host a conference call at 08:30 AM ET on March 24, 2022, to discuss Q4 2021 earnings results. How to Attend HOOKIPA Pharma (HOOK) Conference Call...
Via
Benzinga
68 Biggest Movers From Yesterday
↗
March 03, 2022
Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
